Publications by authors named "J Harbott"

Claim this Profile
F
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.
Meinolf Suttorp, Philipp Schulze, Ingmar Glauche, Gudrun Göhring, Nils von Neuhoff, Jochen Harbott

Leukemia· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, Martin Stanulla, Andrea Biondi, Jochen Harbott

Blood· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Cai Chen, Christoph Bartenhagen, Michael Gombert, Vera Okpanyi, Vera Binder, Jochen Harbott

Leuk Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
A Attarbaschi, R Panzer-Grümayer, G Mann, A Möricke, M König, J Harbott

Klin Padiatr· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
Julie Damgaard Sandahl, Eva A Coenen, Erik Forestier, Jochen Harbott, Bertil Johansson

Haematologica· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis